A research team from Johns Hopkins Medicine and Johns Hopkins University has developed a machine-learning (ML) tool capable of predicting who has the highest probability of being naturally resistant to COVID-19 infection despite being exposed to SARS-CoV-2, the virus that causes it.
The study, published this week in PLOS One, aims to better understand the factors that influence COVID-19 resistance.
“If we can identify which people are naturally able to avoid infection by SARS-CoV-2, we may be able to learn — in addition to societal and behavioral factors — which genetic and environmental differences influence their defense against the virus,” said Karen (Kai-Wen) Yang, lead study author and a biomedical engineering graduate student in the Translational Informatics Research and Innovation Lab at Johns Hopkins University, in the press release. “That insight could lead to new preventive measures and more highly targeted treatments.”
To develop their model, the researchers gathered data from the Johns Hopkins COVID-19 Precision Medicine Analytics Platform Registry (JH-CROWN), which contains information for patients with a suspected or confirmed SARS-CoV-2 infection seen within the Johns Hopkins Health System, the press release states.
From this information, the research team selected patients who had received a COVID-19 test between June 10, 2020, and Dec. 15, 2020, and reported “potential exposure to the virus” as the reason for testing. Dec. 15 was chosen as the end date because it was just before large-scale COVID-19 vaccination efforts began in the US, which allowed researchers to avoid the confounding effects of vaccines, rather than natural resistance, on preventing COVID-19 infection.
The final cohort comprised 8,536 study participants who were divided into two groups: those who either did not share a household with any COVID-19 patients or whose household had 10 or more patients, and those who shared a residence with 10 or fewer people, with at least one being a COVID-19 patient.
The first group, consisting of 8,476 participants, served as the training and initial testing test, while the remaining 60 participants were grouped into a Household Index (HHI) Set, which served as a separate testing set.
EHR data from the cohort was analyzed using the Maximal-frequent All-confident pattern Selection Pattern-based Clustering (MASPC) algorithm, which combines patient demographic information, the relevant International Statistical Classification of Diseases and Related Health Problems (ICD) medical diagnostic codes, outpatient medication orders, and the number of comorbidities present for each patient.
“We hypothesized that MASPC would enable us to cluster patients with similar patterns in their data to define them as resistant and non-resistant to SARS-CoV-2, and with the hope that the algorithm would learn with each analysis how to improve the accuracy and reliability of future assignments,” explained co-senior study author Stuart Ray, MD, vice chair of medicine for data integrity and analytics, and professor of medicine at the Johns Hopkins University School of Medicine, in the press release. “This initial study using JH-CROWN data was conducted to give life to that hypothesis, a proof-of-concept trial of our statistical model to show that resistance to COVID-19 might be predictable based [on] a patient’s clinical and demographic profile.”
The researchers were able to identify 56 of these patterns, five of which captured who was most likely exposed to the virus.
“Looking for these patterns in HHI Set — the individuals most likely to have been exposed to SARS-CoV-2 in close quarters — and then statistically analyzing the results, our model’s best performance was 0.61,” says Ray. “Since a score of 0.5 shows only chance association between the prediction and reality, and 1 is 100% association, this shows the model has promise as a tool for identifying people with COVID-19 resistance who can be further studied.”
The researchers noted that the study has multiple limitations, such as potential bias from the self-reporting of COVID-19 exposure by participants, the small number of participants in the HHI group, the short timeframe of the study, and the possibility that participants may have taken tests for SARS-CoV-2 using home kits or at facilities outside the Johns Hopkins system, which would not have been recorded in the JH-CROWN database.
News
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]
AI outperforms radiologists in brain tumor diagnosis
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct diagnosis is crucial to ensure [...]
Breakthrough Study Reveals Molecular Clues to Dementia Origins
Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified “molecular markers” linked to degeneration—detectable changes in cells and their gene-regulating networks—that are common across several types [...]
Better than blood tests? Nanoparticle potential found for assessing kidneys
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney [...]
Greener nanomaterials could transform how our everyday stuff is made
Tiny nanoparticles are at the forefront of materials science—with special properties that make them great at absorbing light in solar panels, cleaning wastewater, and delivering drugs precisely. Some nanoparticles take the form of sheets or fibers. But nanomaterials all [...]
AI could predict breast cancer risk via ‘zombie cells’
Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the [...]
Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
In a recent study published in the journal Science Advances, researchers leveraged crucial aspects of feline eyes, particularly their tapetum lucidum and vertically elongated pupils (VP), to develop a monocular artificial vision system capable of [...]
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have made promising advances in preventing Alzheimer’s by developing a new therapeutic strategy. Their approach focuses on targeting the amyloid beta [...]
Rewriting Cancer’s Blueprint: New Study Challenges Old Theories
A new study argues for a revised clonal evolution model of cancer, incorporating genetic and non-genetic factors to improve understanding and treatment. Like all living organisms, cancer cells are driven by the fundamental need [...]
Microplastics Everywhere: Experts Demand Worldwide Treaty Before It’s Too Late
A new report calls for global action on plastic pollution, urging reductions in plastic production and microplastic emissions. Researchers stress the importance of addressing plastic pollution through both scientific and social science perspectives. A [...]
Blood tests could soon predict your risk of Alzheimer’s
Scientists are closing in on biomarkers that reflect the progression of Alzheimer’s disease and could improve treatments. Like many Alzheimer’s researchers, neurologist Randall Bateman is not prone to effusiveness, having endured disappointments in his [...]
